OssDsign to Acquire Sirakoss Bone Graft Substitute Company

OssDsign, a Swedish medtech company focused on regenerative implants for improved healing of bone defects, acquired Sirakoss, manufacturer of bone graft substitutes. The acquisition is expected to immediately provide OssDsign with a five times larger addressable market than it presently holds.

The all-cash transaction is valued at USD $11...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us